Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
ANA2MI AS
AS
Active
Org 916518676
Hauganveien 293, 3178
Våle
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2016 · 10 years old
3 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ANA2MI AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
19M
14M
9M
5M
0M
2021: 12M
12M
2021
2022: 14M (+17% vs 2021)
14M
+17%
2022
2023: 15M (+7% vs 2022)
15M
+7%
2023
2024: 13M (-13% vs 2023)
13M
-13%
2024
2025: 15M (+15% vs 2024)
15M
+15%
2025
EBITDA
NOK millions
4M
3M
1M
-1M
-2M
2021: 3M
3M
2021
2022: 2M (-33% vs 2021)
2M
-33%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: -1M (-150% vs 2023)
-1M
-150%
2024
2025: 2M (+300% vs 2024)
2M
+300%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
15 107
12 655
14 598
14 159
12 061
Staff expenses
−2 907
−3 699
−3 037
−2 728
−1 655
EBITDA
2 332
−565
2 300
2 459
3 160
Depreciation & amort.
−0
−14
−41
−43
−38
EBIT
2 332
−578
2 259
2 416
3 121
Net financials
−15
−101
−52
28
−26
Profit before tax
2 317
−679
2 206
2 444
3 096
Tax
381
−0
500
540
690
Net profit
1 936
−679
1 706
1 904
2 406
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
6 321
4 571
5 510
6 338
4 957
Equity
2 811
2 975
3 654
3 448
2 804
Long-term debt
0
0
0
0
0
Short-term debt
3 509
1 596
1 855
2 890
2 153
Total debt
3 509
1 596
1 855
2 890
2 153
Financial ratios
5-year trend
EBITDA margin
15,4 %
This company
15,8 %
Market median
This company
Market median
3% below market
2021
2025
Equity ratio
44,5 %
This company
38,2 %
Market median
This company
Market median
16% above market
2021
2025
Return on equity
68,9 %
This company
18,4 %
Market median
This company
Market median
274% above market
2021
2025
Net profit margin
12,8 %
This company
8,1 %
Market median
This company
Market median
58% above market
2021
2025
Asset turnover
2,39×
This company
1,12×
Market median
This company
Market median
113% above market
2021
2025
Debt / equity
1,25×
This company
0,62×
Market median
This company
Market median
102% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on ANA2MI AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
